Protective effects of a specific platelet activating factor (PAF) antagonist, WEB 2086, in traumatic shock
- 31 January 1989
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 53 (3) , 327-338
- https://doi.org/10.1016/0049-3848(89)90107-2
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Protective Effects of a Platelet Activating Factor (PAF) Antagonist and Its Combined Treatment with Prostaglandin (PG) E1 in Traumatic ShockJournal of Cardiovascular Pharmacology, 1988
- Salutary consequences of blockade of platelet activating factor in hemorrhagic shockEuropean Journal of Pharmacology, 1988
- Coronary vasoconstriction in the rat, isolated perfused heart induced by platelet‐activating factor is mediated by leukotriene C4British Journal of Pharmacology, 1986
- Release of leukotriene C4 by isolated, perfused rat small intestine in response to platelet-activating factor.Journal of Clinical Investigation, 1986
- Role of Platelet-Activating Factor-Acether in Mediating Guinea Pig AnaphylaxisScience, 1986
- Is platelet activating factor (PAF) a mediator of endotoxin shock?European Journal of Pharmacology, 1985
- Platelet activating factor intravenous infusion in rats stimulates vascular lysosomal hydrolase secretion independent of blood neutrophilsBiochemical and Biophysical Research Communications, 1984
- Species specificity of the platelet responses to 1-0-alkyl-2-acetyl--glycero-3-phosphocholineThrombosis Research, 1982
- A QUANTITATIVE METHOD FOR THE PRODUCTION OF EXPERIMENTAL TRAUMATIC SHOCK WITHOUT HÆMORRHAGE IN UNANÆSTHETIZED ANIMALSQuarterly Journal of Experimental Physiology and Cognate Medical Sciences, 1942
- THE ESTIMATION OF CATHEPSIN WITH HEMOGLOBIN AND THE PARTIAL PURIFICATION OF CATHEPSINThe Journal of general physiology, 1937